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Abstract. Urinary markers for renal dysfunction are gaining interest, but effects of sampling method,
storage conditions, and urinary tract inflammation or infection on these markers are unclear. Therefore, the
objectives of the current study were to determine the difference in urinary albumin (uALB), urinary retinol-
binding protein (uRBP), and urinary N-acetyl-b-D-glucosaminidase (uNAG) concentrations in cystocentesis
and voided samples and to investigate concentration changes after storage at 220uC and at 280uC. Effects of
a protease inhibitor were also assessed in samples stored at 280uC for 12 months. In a pilot experiment,
influence of in vitro hematuria, pyuria, and bacteriuria on the urinary markers was evaluated. A mixed model
was used to calculate mean differences and 95% confidence intervals. Urinary ALB, uNAG, and uRBP
concentrations were similar in voided and cystocentesis samples. After storage for 4 months at 220uC, uALB
concentration was not affected, and uRBP concentration showed a mild and clinically irrelevant decrease,
whereas uNAG activity was significantly lower compared with fresh samples. After storage for 12 months at
280uC, uALB and uRBP concentrations did not differ from fresh samples, but uNAG activity was severely
decreased. Protease inhibitor addition did not preserve uNAG activity. Experimental hematuria, pyuria, and
bacteriuria did not seem to affect urinary markers, although further research is needed.
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Introduction
Early diagnosis of decreased kidney function
remains a challenge in veterinary medicine because
of limitations of current diagnostic tests. Traditional
diagnostic markers such as blood urea nitrogen and
serum creatinine will only be increased when already
75% of functional renal mass is lost.8 Measurement
of glomerular filtration rate is a more sensitive
technique but usually requires labor-intensive and
time-consuming clearance tests.32 Therefore, novel
urinary markers that have demonstrated their
potential for early and site-specific detection of
renal dysfunction in human studies are gaining
interest in companion animal medicine.15,21,24,27
Among others, these urinary markers include
intermediate weight proteins such as albumin
(ALB), low molecular weight proteins such as
retinol-binding protein (RBP), and urinary enzymes
such as N-acetyl-b-D-glucosaminidase (NAG). Glo-
merular dysfunction causes increased filtration of
albumin, whereas tubular dysfunction leads to
excessive urinary excretion of RBP and NAG due
to disturbed reabsorption or structural damage of
tubule cells, respectively.10 These markers may not
only allow early diagnosis of primary renal disease,
they are also able to detect subclinical renal
dysfunction secondary to infectious or endocrine
disorders (e.g., pyometra, leishmaniasis, hyperthy-
roidism, and Cushing’s disease).9,12,20,31
In order to perform reliable clinical studies using
urinary markers, urine samples need to be collected
and stored in optimal conditions to preserve protein
integrity and enzyme activity. Studies evaluating the
effect of sampling method and storage conditions on
determination of urinary markers are lacking in
veterinary medicine and therefore mandatory.
Hence, the first objective of the current study was
to determine whether urinary (u)ALB, uRBP, and
uNAG concentrations differ between samples col-
lected by cystocentesis or by free catch. The second
aim was to investigate whether urinary marker
concentrations decrease over time depending on
storage duration and freezing temperature and if a
protease inhibitor (PI) cocktail preserves protein
concentrations in samples stored at 280uC for
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12 months. In a pilot experiment, effects of in vitro




The present study was performed at the Faculty of
Veterinary Medicine, Ghent University (Merelbeke, Bel-
gium), after approval by the Local Ethical Committee.
Eleven privately owned dogs were included (2 neutered
males, 5 intact females, and 4 spayed females), diseased as
well as healthy, to ensure a broad range of urinary marker
concentrations. The study group consisted of 3 healthy
dogs, 1 dog with diabetes mellitus, 1 dog with combined
diabetes mellitus and Cushing’s disease, 1 dog with
Cushing’s disease, and 5 dogs with chronic kidney disease.
Immediately after morning urine samples were obtained by
ultrasound-guided cystocentesis, dogs were walked, and a
voided urine sample was collected from each dog. During
cystocentesis, care was taken to avoid peripheral blood
contamination, and none of the samples showed macro-
scopic discoloration possibly leading to falsely increased
urinary albumin concentrations.29 After centrifugation
(3 min, 447 3 g), a complete urinalysis (dipstick,a urine
specific gravity, urine protein-to-creatinine ratio, sediment
analysis, and bacterial culture) was done on cystocentesis
samples. Dipstick and sediment analyses of the voided
samples were also performed. The remaining supernatant
was divided into aliquots of 0.5 ml and frozen at 220uC
and 280uC. Sufficient aliquots were frozen to avoid
multiple freeze–thaw cycles during future analyses. Fifty
microliters of PI cocktailb was added to 1 ml of cystocen-
tesis and voided urine, and 4 aliquots of each were frozen at
280uC. One aliquot of both cystocentesis and voided
samples was used immediately for measurement of uALB,
uRBP, and uNAG in fresh samples.
Analysis of urinary markers
Urinary ALB, uRBP, and uNAG concentrations were
measured in cystocentesis and voided samples within 3 hr
after collection (time 0: T0) and after 4 months of storage at
220uC (time 4 months: T4 months). Furthermore, urinary
markers were determined in cystocentesis samples after
12 months of storage at 220uC and at 280uC (time
12 months: T12 months) and in PI samples stored at 280uC.
Urinary ALB concentration was determined with a
commercial canine-specific sandwich enzyme-linked immu-
nosorbent assay (ELISA) kit,c uRBP with a human ELISA
kit,d and uNAG activity using a colorimetric assay,e as
previously validated and described.15,27 Mean interassay
coefficient of variation was 12.0% for uALB analysis, 8.5%
for uRBP, and 8.1% for uNAG.15,27
Effect of hematuria, pyuria, and bacteriuria
Cystocentesis urine samples of 2 healthy dogs were used
to evaluate the effect of experimental hematuria, pyuria,
and bacteriuria on uALB, uRBP, and uNAG concentra-
tions. A heparinized blood sample of 1 healthy dog was
used to mimic hematuria and to isolate white blood cells.
Whole blood was diluted 4,000- and 16,000-fold in the
urine samples, yielding a 3+ and 1+ hematuria on dipstick
analysis,f respectively. Furthermore, white blood cells were
isolated after gradient centrifugation on Percoll.g,28 Briefly,
2 ml of blood was layered carefully on Percoll with a
density of 1.077. The tube was centrifuged at 340 3 g for
30 min at room temperature. Then plasma was discarded,
and the opaque band containing the white blood cells at the
interface between plasma and the Percoll layer was
aspirated with a Pasteur pipette and transferred into a
conical tube. After 3 washing steps in a phosphate buffered
saline solution, the white blood cells were counted.h
Cytospin preparationsi were stainedj and showed isolated
white blood cells to consist mainly of neutrophils (74%)
and further of lymphocytes (21%) and monocytes (5%).
White blood cells were added to the urine samples until a
final concentration of approximately 80 white blood cells
per ml was obtained, corresponding with 1+ pyuria on
dipstick analysis.
For the bacteriuria experiment, Escherichia coli bacteria
were grown overnight, and bacterial concentration was
determined using a standard curve plotting the colony
forming units (CFUs) as a function of the absorbance at
550 nm. Bacteria were diluted in the urine samples until a
final concentration of 105 CFU per ml was obtained.
All urine samples (i.e., 1+ and 3+ hematuria, 1+ pyuria,
and bacteriuria) and blank urine samples were incubated at
38uC for 2 hr to simulate a retention period in the bladder
at body temperature. After centrifugation (3 min at 447 3
g), the supernatant was divided into aliquots of 1 ml and
stored at 280uC until analysis within 2 weeks. Addition-
ally, blank urine samples without incubation at 38uC were
also centrifuged and stored at 280uC as negative controls.
Urinary ALB, uRBP, and uNAG concentrations were
compared between blank samples and hematuria, pyuria,
and bacteriuria samples of the 2 dogs to assess the effect of
red blood cell, white blood cell, and bacterial contamina-
tion.
Statistical analysis
Analyses were performed with a commercial software
programk using a mixed model with dog as random effect,
and with collection method, storage time, freezing temper-
ature, and addition of PI as categorical fixed effects.
Urinary ALB, uRBP, and uNAG concentrations were
compared between cystocentesis and voided samples at T0
and at T4 months. Urinary marker concentrations at T4 months
and T12 months were compared with concentrations at T0. At
T12 months, uALB, uRBP, and uNAG concentrations in
samples stored at 280uC with and without PI were
compared with each other and with T0 samples. All tests
were performed at 5% significance level.
Mean differences between sampling techniques, storage
time, and temperature with 95% confidence intervals (CIs)
were derived. Equivalence between sampling techniques or
between storage conditions can be claimed when the CI is
contained in a region of differences, which is considered to
be clinically irrelevant. To calculate the mean percentage
change of uALB, uRBP, and uNAG over time, a simple
regression analysis was performed with difference at 2 time
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points as response variable and the value at earliest time
point as covariate.
Results
There was no statistically significant difference in
uALB, uRBP, and uNAG concentrations between
cystocentesis and voided urine samples at T0 or
T4 months (P . 0.05). Mean differences between
cystocentesis and voided samples at T0 and T4 months
are presented in Figure 1.
Differences in uALB, uRBP, and uNAG concen-
trations after storage at 220uC and 280uC are also
shown in Figure 1. At T4 months after storage at
220uC, uALB concentration was not significantly
different from T0 (P . 0.05), with a mean difference
of 29.96 mg/l (95% CI: [218.55; 51.48]). Urinary RBP
concentration was significantly but mildly decreased
(P 5 0.02), with a mean difference of 40.11 mg/l (95%
CI: [12.51; 67.71]). Urinary NAG activity was
significantly lower compared with T0, with a mean
decrease of 0.61 U/l (95% CI: [0.27; 0.95]; P 5 0.005).
Mean percentage decrease 6 standard error (SE) was
15% 6 3% for uRBP and 20% 6 11% for uNAG,
respectively.
At T12 months after storage at 220uC, uALB and
uNAG concentrations were significantly lower than
at T0 (P 5 0.006 and P , 0.0001, respectively). Mean
difference was 99.83 mg/l (95% CI: [44.25; 155.4]) and
2.87 U/l (95% CI: [2.13; 3.6]) for uALB and uNAG,
respectively. For uALB, mean percentage decrease
6 SE was 20% 6 6% and for uNAG 92% 6 4%.
Urinary RBP was not significantly different com-
pared with T0 (P . 0.05), with a mean difference of
37.92 mg/l (95% CI: [22.13; 77.97]).
At T12 months after storage at 280uC, only uNAG
activity showed a significant decrease of 2.7 U/l (95%
CI: [2.09; 3.3]) compared with T0 (P , 0.0001), with a
mean decrease of 89% 6 5%. Urinary ALB and
uRBP concentrations did not differ significantly from
T0 (P . 0.05), with a difference of 42.89 mg/l (95%
CI: [215.33; 101.1]) and 7.3 mg/l (95% CI: [24.84;
19.44]), respectively.
Samples with addition of PI were analyzed only at
T12 months after storage at 280uC. Urinary ALB,
uRBP, and uNAG concentrations were not statisti-
cally different in samples with PI compared with
samples stored without PI (P . 0.05). Urinary NAG
activity remained significantly lower compared with
T0 (P , 0.0001), regardless of PI addition.
As presented in Table 1, uALB, uRBP, and uNAG
concentrations did not differ between blank samples
and urine samples with 1+ hematuria, 1+ pyuria, and
bacteriuria. Urinary ALB and uRBP, but not uNAG
concentration, showed a very mild increase in samples
with 3+ hematuria.
Discussion
Results of the present study demonstrate that
uALB, uRBP, and uNAG concentrations do not
differ significantly between cystocentesis and voided
urine samples. In contrast, storage conditions may
affect uALB and uRBP concentrations and uNAG
enzyme activity. Results also suggest that the addition
of a PI cocktail does not preserve uNAG activity after
long-term storage at 280uC. Effects of experimental
microscopic hematuria, pyuria, and bacteriuria on
these urinary marker concentrations seem to be
minimal, although these in vitro results do not reflect
the complexity of an inflammatory process in vivo,
and further research is needed.
In human medicine, there are many reports on
urine sample storage conditions, their effect on
protein concentrations and on subsequent data
interpretation.4,11,16,17,26 To the authors’ knowledge,
the effect of sampling method on urinary marker
concentrations has never been reported in dogs or
cats. In reports on uALB, uRBP, or uNAG in canine
or feline urine, cystocentesis as well as catheterization
and midstream voided urine have been used.12,19,30 In
contrast to voided samples, cystocentesis avoids
contamination with lower urinary tract epithelial
cells, proteases, and bacteria that may affect urinary
markers.22 When performing cystocentesis, care must
be taken to avoid peripheral blood contamination
leading to grossly discolored urine samples, since this
may cause a falsely increased urinary albumin
concentration.29 However, results of the present study
did not indicate a statistically significant difference in
uALB, uRBP, or uNAG concentrations between
cystocentesis and voided samples at T0 and at
T4 months after storage at 220uC. Despite this general
finding, 1 dog with combined diabetes mellitus and
Cushing’s disease, and a negative urine culture, had
increased uALB, uRBP, and uNAG concentrations in
the voided sample (voided: uALB, 183.17 mg/l;
uRBP, 71.1 mg/l; uNAG, 5.86 U/l; cystocentesis:
uALB, 33 mg/l; uRBP, 29.8 mg/l; uNAG, 1.51 U/l).
In this male castrated dog, macroscopic hematuria
was not present in either the cystocentesis or voided
sample. Sediment analysis of the cystocentesis sample
did not reveal pyuria or inflammation. However, in
the sediment of the voided sample, increased amounts
of red blood cells, white blood cells, and epithelial
cells were detected. Therefore, one hypothesis might
be that urethral inflammation or preputial disease
caused severe contamination of the urine sample,
which affected the urinary markers. This finding
suggests that other components of the inflammatory
response, not mimicked by the in vitro experiment,
may also play a role. Although, in general, a
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Figure 1. Mean differences in (A) urinary albumin (uALB), (B) urinary retinol-binding protein (uRBP), and (C) urinary N-acetyl-
b-D-glucosaminidase (uNAG) concentrations between cystocentesis and voided samples in fresh urine and after storage for 4 months at
220uC, and between fresh urine samples and samples stored at 220uC and at 280uC for 4 and 12 months.
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significant difference between cystocentesis and
voided samples was not detected, possible inter-
individual variations should be considered.
To the authors’ knowledge, there are no reports in
the veterinary literature on stability of uRBP, uALB,
and uNAG after frozen storage. At T4 months after
storage at 220uC, uALB concentration was compara-
ble with T0. In human medicine, there are contradic-
tory reports on uALB stability. Results of the present
study are in agreement with previous studies that
describe no significant change in uALB concentration
after storage at220uC for up to 6 months.3,7 However,
others detected a decrease of 20% in uALB concen-
tration after 6 months at220uC.26 In the present study,
uRBP was significantly lower at T4 months compared
with T0. Nevertheless, this decrease was mild (40.11
mg/l), and the entire 95% CI was within a clinically
acceptable range. Moreover, the RBP ELISA range of
analytical variation for canine urine is 15.6% (mean
interassay coefficient of variation + 23 standard
deviation) and mean percentage decrease of uRBP
reported herein was 15%.15 Therefore, the decrease in
uRBP may be due to assay variation. Urinary NAG
was significantly lower at T4 months compared with T0,
with a mean percentage decrease of 20%. This finding
corresponds to results of studies in human medicine,
which demonstrated a 25.6% decrease in uNAG after
2 months of storage at 220uC.2
While both uALB concentration and uNAG
activity were significantly decreased at T12 months after
storage at220uC, only uNAG was significantly lower
compared with T0 after storage at 280uC. For uALB,
these findings are similar to previous results demon-
strating a significant decline in human uALB after
12 months at 220uC, but not at 280uC.11 In the
present study, uNAG was dramatically decreased at
T12 months with losses of 92% at 220uC and of 89% at
280uC. Addition of a PI cocktail had no effect on the
preservation of uNAG. The decrease at 280uC was
unexpected because studies in human medicine
indicated a largely preserved uNAG activity (84.6%)
after storage for 12 months at 270uC.17 Still,
components of canine urine differ from human urine,
and enzyme activities are influenced by many factors,
such as temperature, pH, specific inhibitors, creati-
nine, urea, and electrolytes.13 Alkaline pH (.8)
causes a rapid decrease of uNAG, but urinary pH
values in the present study ranged from 5.5 to 8, and
only 1 sample had a pH of 8.13,18
At T12 months after storage at 220uC, uRBP was not
significantly lower compared with T0. This may seem
contradictory because uRBP was mildly decreased at
T4 months. However, the former decline is probably due
to assay variability, and none of the observed differences
is so large as to have clinical relevance. In the current
study, storage at220uC for 4–12 months seems to have
only minimal effects on uRBP concentration. This
finding is in contradiction with results obtained from
human samples demonstrating decreased uRBP con-
centrations after storage at 220uC for 6–8 months.
However, it must be noted that only a minority of
samples in the latter study showed substantial underes-
timation.26 At T12 months after storage at 280uC, the
present study indicated no significant difference in
uRBP compared with T0. This is in accordance with
data from human medicine demonstrating no significant
change in uRBP when stored at 270uC for 8 months.26
Guidelines advise diagnosticians to exclude urinary
tract inflammation or infection (UTI) before identi-
fying the origin of proteinuria because it influences
urinary total protein-to-creatinine ratio.1,14 However,
the effect on other urinary markers is currently
unclear. In human medicine, there is no evidence
that asymptomatic UTI causes proteinuria or albu-
minuria.6 Results of the present pilot experiment
suggest that experimental pyuria, 1+ and 2+ hematu-
ria, and bacteriuria do not affect uALB, uNAG, or
uRBP concentrations. However, these findings have
Table 1. Urinary marker concentrations in blank urine samples and urine samples with experimental hematuria, pyuria,
and bacteriuria.*
Dog 1 Dog 2
uALB (mg/l) uRBP (mg/l) uNAG (U/l) uALB (mg/l) uRBP (mg/l) uNAG (U/l)
Blank samples
0 hr incubation 25.9 161.6 1.8 2.9 BDL BDL
2 hr incubation at 38uC 34.2 163.7 1.4 3.5 BDL BDL
Hematuria
RBC 1+ 34.1 183.7 1.9 3.4 BDL BDL
RBC 3+ 40.5 217.1 1.9 8.1 58.3 BDL
Pyuria 1+ 35.7 160.9 2.1 3.6 BDL BDL
Bacteriuria 34.9 164.4 1.9 4.4 BDL BDL
* uALB 5 urinary albumin; uRBP 5 urinary retinol-binding protein; uNAG 5 urinary N-acetyl-b-D-glucosaminidase; BDL 5 below
detection limit; RBC 5 red blood cells.
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to be interpreted with caution because in vitro
addition of leucocytes or bacteria to urine does not
fully reflect an in vivo inflammatory process, with its
complex interactions between stimulated leucocytes
and bacteria involving inflammatory cytokines, bac-
terial products, and urinary molecules released from
various sources. Samples with 3+ hematuria had a
negligible increase in uALB and uRBP, probably
caused by contamination of plasma albumin and RBP
through addition of whole blood to the urine samples.
These results are in agreement with previous data
from canine urine samples showing no increased
uALB in the majority of pyuric samples and a uALB
above normal range only in macroscopically hema-
turic samples.29 Two studies report similar canine
uNAG activity in samples with or without hematuria,
asymptomatic bacteriuria, or positive urine cul-
tures.5,12 One report showed increased uNAG con-
centration in dogs with pyelonephritis but not in dogs
with lower UTI.25 Effects of UTI on uRBP have not
been reported in veterinary medicine. Data from
human medicine, however, showed increased uRBP in
patients with acute pyelonephritis, but not in patients
with cystitis or asymptomatic bacteriuria.23
Limitations of the present study are that data were
obtained at only 3 time points (0, 4, and 12 months) in a
relatively small sample group and that the effect of a PI
was examined after 12 months at 280uC, but not at
220uC. The pilot experiment to assess effects of
hematuria, pyuria, and bacteriuria is limited because
it does not fully mimic the complexity of an in vivo
cystitis. Therefore, further work is needed to evaluate
the true influence of UTI on these urinary markers. The
study was not designed to clarify underlying mecha-
nisms of storage effects on the markers but provides
essential information regarding storage conditions for
further research in the domain of urinary markers.
In conclusion, samples for analysis of uALB and
uRBP can be stored at 220uC for up to 4 months,
whereas 280uC is preferred for storage up to
12 months. Urinary NAG enzyme activity is less
stable at 220uC as well as 280uC, with already
substantial losses after 4 months at 220uC and a
more severe decline after 12 months at 280uC.
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